Healthcare Services

Long‑Read Sequencing Services Market Expected To Witness Revenue Growth Toward $2.78 Billion By 2030

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Long‑Read Sequencing Services Market Change Between 2026 And 2030?

The long‑read sequencing services market has seen rapid growth in recent years. It is forecast to grow from $1.18 billion in 2025 to $1.41 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.9%. The market’s expansion in the past can be attributed to developments in sequencing chemistry and instruments, increased funding allocated to genomics research, a growing need for high-resolution genome analysis, the expansion of academic genomics projects, and the presence of specialized sequencing service providers.

The long-read sequencing services market size is anticipated to experience substantial expansion over the coming years. This market is projected to reach $2.79 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 18.6%. The projected expansion during this period stems from several factors, including the increasing clinical integration of long-read sequencing, a surge in investments directed towards population genomics, the broadening scope of precision oncology research, an escalating need for de novo genome assembly, and the incorporation of AI-driven genomic interpretation. Key developments expected throughout the forecast horizon involve a heightened demand for services related to structural variant analysis, a growing embrace of nanopore sequencing platforms, the expanding application of long-read sequencing in researching rare diseases, the proliferation of clinical-grade long-read sequencing services, and a reinforced emphasis on achieving comprehensive genome assembly.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28260&type=smp

What Core Drivers Are Transforming The Long‑Read Sequencing Services Market?

The increasing occurrence of genetic conditions is anticipated to fuel expansion in the long-read sequencing services market moving ahead. Genetic ailments represent conditions stemming from alterations or mutations within DNA, capable of being passed down through inheritance or arising spontaneously, impacting an individual’s health, development, or physiological functions. The surge in genetic disease prevalence can be attributed to heightened awareness and progress in diagnostic tools, which facilitate earlier and more precise identification of previously undetected conditions. These long-read sequencing services aid in the management of genetic disorders by furnishing highly accurate, extensive genomic information, thereby allowing for the exact identification of structural variations and intricate mutations. As an illustration, in April 2024, data from the National Institutes of Health (NIH), a leading US government biomedical research agency, indicated that approximately 6.9 million Americans aged 65 and above are presently affected by Alzheimer’s dementia, with this number forecasted to nearly double to 13.8 million by 2060. Consequently, the expanding incidence of genetic disorders is propelling the expansion of the long-read sequencing services market.

How Is The Long‑Read Sequencing Services Market Examined Through Segment Analysis?

The long‑read sequencing services market covered in this report is segmented –

1) By Service Type: Whole Genome Sequencing, Targeted Sequencing, De Novo Sequencing, Other Services

2) By Technology: Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies

3) By Application: Clinical Diagnostics, Genomic Research, Oncology, Rare Disease Detection, Other Applications

4) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Whole Genome Sequencing: Complete Genome Mapping, Comprehensive Variant Detection, Structural Variation Analysis, Comparative Genomics

2) By Targeted Sequencing: Gene Panel Sequencing, Exome Sequencing, Transcriptome Sequencing, Custom Target Region Sequencing

3) By De Novo Sequencing: Novel Genome Assembly, Structural Variant Characterization, Complex Genome Reconstruction, Non-Model Organism Sequencing

4) By Other Services: Data Analysis And Interpretation, Library Preparation Services, Bioinformatics Support Services, Validation And Quality Control Services

Which Trends Are Expected To Shape The Long‑Read Sequencing Services Market?

Leading companies in the long-read sequencing services market are concentrating on developing innovative solutions, such as primary template-directed amplification (PTA), which enables high-fidelity uniform whole-genome amplification from individual cells by allowing for the sensitive detection of single-nucleotide variants (SNVs). Primary template-directed amplification is a proprietary whole-genome amplification method designed to accurately and uniformly amplify deoxyribonucleic acid (DNA) from ultra-low input samples, achieving this by minimizing errors and preserving the original deoxyribonucleic acid (DNA) sequence. For example, in October 2025, BioSkryb Genomics, Inc., a US-based genomics company specializing in long-read sequencing technologies, launched the ResolveSEQ LongRead Early Access Program. This cutting-edge single-cell whole-genome long-read sequencing platform integrates primary template-directed amplification (PTA) with long-read library preparation to provide high-coverage, uniform amplification from individual cells. Additionally, the platform allows for sensitive detection of single-nucleotide variants (SNVs) and repeat expansions while offering haplotype phasing at single-cell resolution.

Which Organizations Are Operating Within The Long‑Read Sequencing Services Market?

Major companies operating in the long‑read sequencing services market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., Macrogen Inc., Novogene Co. Ltd., DNAnexus Inc., Zymo Research Corp., CD Genomics Inc., Genotypic Technology Pvt. Ltd., Plasmidsaurus Inc., BaseClear B.V., GrandOmics Biosciences Co. Ltd., Arima Genomics Inc., Wuhan Benagen Technology Co. Ltd.

Access The Complete Long‑Read Sequencing Services Market Report:

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-services-global-market-report

Which Region Stands As The Largest Contributor To The Long‑Read Sequencing Services Market?

North America was the largest region in the long‑read sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long‑read sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Long‑Read Sequencing Services Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28260&type=smp

Browse Through More Reports Similar to the Global Long‑Read Sequencing Services Market 2026, By The Business Research Company

Anti Parkinson Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

Regenerative Medicine Market 2026

https://www.thebusinessresearchcompany.com/report/regenerative-medicine-market

Dermatophytosis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatophytosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795